Growth Metrics

Forte Biosciences (FBRX) Assets Average (2017 - 2020)

Forte Biosciences (FBRX) has disclosed Assets Average for 4 consecutive years, with $25.5 million as the latest value for Q3 2020.

  • Quarterly Assets Average fell 67.28% to $25.5 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $25.5 million through Sep 2020, down 67.28% year-over-year, with the annual reading at $55.4 million for FY2019, 43.26% down from the prior year.
  • Assets Average for Q3 2020 was $25.5 million at Forte Biosciences, up from $23.5 million in the prior quarter.
  • The five-year high for Assets Average was $106.5 million in Q3 2017, with the low at $13.1 million in Q1 2020.
  • Average Assets Average over 4 years is $68.9 million, with a median of $83.0 million recorded in 2018.
  • The sharpest move saw Assets Average soared 145.26% in 2018, then plummeted 86.71% in 2020.
  • Over 4 years, Assets Average stood at $97.1 million in 2017, then decreased by 0.42% to $96.7 million in 2018, then crashed by 59.47% to $39.2 million in 2019, then tumbled by 34.9% to $25.5 million in 2020.
  • According to Business Quant data, Assets Average over the past three periods came in at $25.5 million, $23.5 million, and $13.1 million for Q3 2020, Q2 2020, and Q1 2020 respectively.